Sprachauswahl: DE | EN
Rapid Microbiological Methods and Mycoplasma Testing
20 November 2018
This conference will review the current knowledge about developments in modern microbiological methods and mycoplasma detection strategies for quality control in biopharmaceutical manufacturing.
This one-day meeting provides the opportunity to discuss the recent advances in the area of the newest technological developments as well as practical aspects and concerns of meeting the regulatory requirements. State-of-the-art presentations from authority speakers, as well as industrial and academic experts in the field of microbiological detection and identification and mycoplasmology with particular focus on the current methodologies their implementation and validation will provide an in-depth overview.
The scientific progress in the field of cellular and molecular biotechnology led to a fast development of biopharmaceuticals, tissue engineered applications and advanced therapy medicinal products (ATMPs). Against this background, the safety of such new technologies, products and applications becomes more importance. One important topic in the focus of risk assessment and safety is the contamination with microorganisms and mycoplasmas and their detection, prevention and control.
This conference is of interest to professionals from
- Biotechnological & Biopharmaceutical Companies
- Contract Service Laboratories
- Academic Research Institutions and Organizations
- Government Agencies
- Cell Culture Collections
- Supplier Detection Systems
with responsibilities in
- Quality Assurance
- Quality Control
- Regulatory Affairs
- Research & Development
- Process Development
Werden Sie Teil des PharmaLab-Kongresses 2018 – als Referent
Füllen Sie hierzu bis zum 23. März 2018 unser Online-Formular aus.